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College of Medicine, Houston, TexasABSTRACT The aggregation of a-synuclein is associated with progression of Parkinson’s disease. We have identified
submicrometer supramolecular structures that mediate the early stages of the overall mechanism. The sequence of
structural transformations between metastable intermediates were captured and characterized by atomic force microscopy
guided by a fluorescent probe sensitive to preamyloid species. A novel ~0.3–0.6 mm molecular assembly, denoted the
acuna, nucleates, expands, and liberates fibers with distinctive segmentation and a filamentous fuzzy fringe. These fuzzy fibers
serve as precursors of mature amyloid fibrils. Cryo-electron tomography resolved the acuna inner structure as a scaffold of
highly condensed colloidal masses interlinked by thin beaded threads, which were perceived as fuzziness by atomic force
microscopy. On the basis of the combined data, we propose a sequential mechanism comprising molecular, colloidal, and
fibrillar stages linked by reactions with disparate temperature dependencies and distinct supramolecular forms. We anticipate
novel diagnostic and therapeutic approaches to Parkinson’s and related neurodegenerative diseases based on these new
insights into the aggregation mechanism of a-synuclein and intermediates, some of which may act to cause and/or reinforce
neurotoxicity.INTRODUCTIONThe aggregation of the presynaptic 140 aa (14.5 kDa) protein
a-synuclein (AS) is a prominent cytopathological feature of
Parkinson’s disease (PD), manifested by the deposition of
dense tangles of fibrils with a characteristic amyloid cross-
b-sheet secondary structure in dopaminergic neurons of the
substantia nigra and related nuclei of the midbrain (1,2).
Neuronal dysfunction or death due to protein aggregation is
also characteristic of other neurodegenerative conditions,
such as Alzheimer’s disease (AD) (3). Diagnosis has relied
exclusively on clinical assessment, and current therapy is
palliative and temporary. Although predictive molecular
markers (4) and strategies based on molecular features (5)
are emerging, at this time, PD cannot be prevented or cured.
Mature amyloid fibrils of AS predominate in the Lewy
bodies and Lewy neurites characteristic of PD and other
synucleopathies (2). However, numerous investigations
indicate that neurotoxicity may instead derive from soluble,
oligomeric, ‘‘mysterious’’ (6) reaction intermediates (7,8).
Thus, the molecular constituents of inclusion bodies (>8
proteins in the case of Lewy bodies (9)) may serve as
witnesses to rather than as the cause of cell degeneration.
It has been proposed that oxidative modifications, mito-Submitted November 30, 2011, and accepted for publication January 26,
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protein degradation resulting from environmental expo-
sure, genetic factors, and endogenous insults constitute a
‘‘Bermuda triangle’’ of neurodegeneration (10).
Numerous fluorescent probes are applied in studies of
amyloid aggregation (11,12). Unfortunately, organic com-
pounds such as thioflavin T (ThT), which is used to demon-
strate mature amyloid fibrils in assays or in cytochemical
staining, are insensitive to prefibrillar precursors. Our recent
studies of AS aggregation have been based on fluorescent
compounds exhibiting excited-state intermolecular proton
transfer (ESIPT). Excited-state tautomerism leads to a dual
emission that is extremely sensitive to local molecular
features such as polarity and hydrogen bonding (13). Thus,
ESIPT probes providemultiple fluorescent signals, including
absolute intensities of the N* (normal) and T* (tautomer)
bands, T*/N* ratio, polarization, spectral position(s), and
lifetime(s). In our first application of such fluorophores we
used an extrinsic dye (FE) that is able to distinguish between
wild-type (wt) and familial mutant fibrillar forms of AS (14).
To explore the critical initial, elusive phases of the aggre-
gation mechanism, we switched to covalent adducts of
ESIPT probes (e.g., MFC), inserted at defined sequence
positions (18, 90, 140) of functionally neutral Ala-to-Cys
AS mutants (15). Mixtures of unlabeled wtAS and a low
reporter concentration (~3%) of labeled protein exhibited
multiple and pronounced spectroscopic changes during
the early stages of AS aggregation, i.e., before the appear-
ance of an appreciable ThT response. The effects weredoi: 10.1016/j.bpj.2012.01.051
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bonding, and motional constraint of the protein-attached
probe, with clear distinctions between the properties of the
fibrillar amyloid end state and its apparent precursors.
To establish the structural identity of the latter, we
sampled the reactions at various intervals by atomic force
microscopy (AFM), guided by the temporal course of the
ESIPT T*/N* ratio. This evaluation led to the recognition
(reported here) of a family of supramolecular entities arising
and disappearing in a well-defined orchestrated sequence.
We have named a key subpopulation of this family acunas,
a contraction of the word ‘‘amyloid’’ and the Spanish word
‘‘cuna’’ (cradle in English). The term is prompted by the
appearance of oval-to-round supramolecular assemblies
(diameterR200 nm) upon which distinct highly segmented
and laterally decorated (fuzzy) fibers nucleate, extend, and
are then liberated. We have distinguished at least eight
distinct molecular species by AFM.
Because AFM is exclusively a probe of surface topology,
we resorted to cryo-electron tomography (cryo-ET) to inves-
tigate the inner structure of the acuna under fully hydrated
conditions. Cryo-ET is a method of choice for investigating
large, pleomorphic supramolecular assemblies (16–18),
either in isolated form or in their cellular environment.
The electron micrographs provide two-dimensional (2D)
projections of a three-dimensional (3D) object that is vitri-
fied in solution before examination. To retrieve 3D struc-
tures, we tilted the specimens with respect to the electron
beam while recording a series of 2D images at different
projections. We then reconstructed a tomogram of the 3D
volume from the annotated stacks of image data (see Fig. 4).
Most electron microscopic and tomographic studies of
biological structures rely on conventionally prepared speci-
mens subjected to chemical fixation, staining, dehydration,
and embedding. However, these procedures can result in
severe structural artifacts (19,20). In contrast, cryo-electron
microscopy uses specimens that are isotropically vitrified in
appropriate buffers or solutions at liquid nitrogen tempera-
ture, which preserves their close-to-native conformation
(21). In addition, the specimens are maintained at tempera-
tures near 180C during microscopy, which effectively
lessens the overall radiation damage.MATERIALS AND METHODS
AS and aggregation assays
Aggregation assays of wtAS protein in combination with cysteine-contain-
ing mutants labeled with the MFC ESIPT probe were performed at 4C,
37C, and 70C as described previously (15). Procedures are described in
the Supporting Material.Atomic force microscopy
A detailed description of the AFM sample preparation and image analysis
(morphological analysis approaches and procedures) is given in the Sup-
porting Material.Biophysical Journal 102(5) 1127–1136Cryo-ET
Details regarding specimen preparation and Cryo-ET procedures are
provided in the Supporting Material.Image processing
Tomographic reconstruction and image processing were performed using
IMOD software (22) and the EMAN2 (23) package for Linux. The tilt series
was normalized via IMOD to avoid uneven distribution of intensities.
Projection images (10481048) were aligned to a common origin, using
selected areas of high contrast, and reconstructed by means of weighted
back-projection via eTomo, a graphical user interface (GUI) to the IMOD
Tomography package. The featured tomogram was binned by a factor of
2 and low-pass filtered to 100 A˚ using the EMAN2 software package.Tomogram annotation
For segmentation of the reconstructed tomogram, were identified and ex-
tracted individual features, such as the beaded threads and condensed
colloidal masses, in silico. We then calculated 2D images of these elements
by projecting the volumes along the z axis using AMIRA 5.2 software
(Visage Imaging GmbH, Berlin). Visualizations were constructed with
the use of surface-rendering operations in AMIRA 5.2 software. To assist
visualization, structural features were segmented from the binned, low-
pass filtered tomogram with Amira Brush and Blow tools. The AS beaded
threads and condensed colloidal masses were subjectively colored in
a purple-to-red gradation along the z axis, and the acuna and surrounding
features were subjectively colored in yellow. To ensure accurate segmenta-
tion, slices above and below each beaded thread and condensed colloidal
mass in the z axis were manually tracked to verify their continuity
throughout the slices. Unclear, low-contrast features lacking continuity
throughout the slices were designated as noise.RESULTS
AS aggregation and AFM
The time course of the aggregation reaction conducted at
37C of wtAS þ 2.5% A140C-MFC was monitored by
means of the T*/N* ratiometric signal of the ESIPT probe
and later by the ThTassay (Fig. 1 A). As reported previously
(15), the T*/N* ratio rose, peaked, diminished, and then
stabilized before the appearance of the maximal ThT
response. Samples were taken for examination by AFM at
the indicated times (Fig. 1, A and C). Reproducibility was
obtained in the aggregation experiments by ultracentrifuga-
tion of the initial monomeric protein, resulting in ruffled
film on the mica surface devoid of nano- and microaggre-
gates (Fig. 1, A and C; Fig. 2, A and B; and Fig. S1 in the
Supporting Material).
During the initial ~15 h of AS self-assembly, the system
evolved into a series of oligomeric and supramolecular enti-
ties (Fig. 1 C.2–5), which arose and disappeared in succes-
sion. The final supramolecular product consisted
exclusively of mature amyloid fibrils (mafs; Fig. 1 C.6).
At 70C, the aggregation reaction was significantly accel-
erated (14) without affecting the nature and sequence of the
intermediates, although the high temperature led to an
apparent chemical degradation of the ESIPT probe (15).
FIGURE 1 Aggregation of ESIPT-labeled AS. (A)
Reaction at 37C. T*/N* ratio (blue dots) and ThT
(black dots and solid fit line). The ThT transition midpoint,
t1/2, was ~30 h. AFM sample points are shown in red. (B)
Field with multiple acuna structures of an incubation at
70C; image acquired at 12 h. (C) AFM images represen-
tative of different oligomeric species found during the
course of reaction corresponding to the wtAS control
sample in panel A. The sampling times and names (see
text) are indicated in each panel. AS: wt þ 2.5%
AS140C-MFC (15). Scale bars: 500 nm.
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family of intermediates (Fig. 1 B, Fig. S13, and Fig. S14),
including acunas (see Introduction). In contrast, in reactions
conducted at 4C, there were no changes in fluorescence and
supramolecular fiber-free latent acunas (see below) accu-
mulated as the end product.
From the data obtained in these and numerous other
highly reproducible experiments, we constructed a gallery
of representative images characterizing the family of inter-
mediates (Fig. 2). Statistical estimations of the key struc-
tural parameters (heights, diameters and periods) are given
in Fig. 3. A number of conditions (color-coded) are repre-
sented in Fig. 2, including wtAS in the presence and absence
of labeled protein as well as incubations at 4C, 37C, and
70C with mechanical agitation (except for panels C and D).
The panels of Fig. 2 feature subimages (ranging from 0.7
to 50 mm) culled from AFM scan fields of samples applied
to the mica surface by spin-coating (except for panel E).
This procedure is ideally suited for particulate and fibrillar
material, which is dispersed into a thin film before drying
(24) (see Supporting Material). The AS supramolecular
forms were observed over and embedded within the
layer of monomer, which adhered quickly and strongly
to the mica. No differences were observed between the
images obtained with protein with or without a labeled
subpopulation.The fuzzy ball (fb), the earliest perceptible structure in
incubations at all temperatures (Fig. 2, A and B), is a nano-
sphere with a height of ~4 nm; the apparent lateral diameter
(305 4 nm) is dilated by convolution with the finite AFM
tip diameter. The fb exhibits a progressive tendency to
recruit material at its periphery (~1 nm height) perceived
as fuzziness. Coalescing into an accretion zone with up to
five round entities, the fbs lead to the formation of distinc-
tive supramolecular structures, the acunas.
Acunas appear as an oblong or circular discs byAFM in air
(top view), but as oblate ellipsoids by cryo-ET (Fig. 4). We
attribute the collapse of the air-dried AFM samples to the
loss of hydration stabilizing the tenuous internal struc-
ture preserved by the isotropic vitrification procedure of
cryo-ET. Given a sufficiently high protein concentration
(e.g.,R200 mM), acunas form spontaneously at 4Cwithout
agitation (Fig. 2, C and D), but are also observed at higher
temperatures with agitation (Fig. 2, E–N). The diameters
are 200–250 nm and the heights are 15–40 nm (Fig. 3). Latent
acunas generated at 4C are distinguished by a central area
with discrete particles that are presumed to originate by coa-
lescence of fbs (Fig. 2 D). At 4C, the acunas do not proceed
further in the aggregation process (attached fibers are absent;
Fig. 3) and exhibit neither an appreciable fluorescent ESIPT
response (increase in T* and N* band intensities; Fig. 1 A)
nor a b-strand circular dichroism signature.Biophysical Journal 102(5) 1127–1136
FIGURE 2 AFM images of AS aggregation intermediates. (A and B) Fuzzy balls. (C–E) Latent acunas. (F–N) Productive acunas. (O–Q) Fuzzy fibers. (R)
Denuded fibers. (S) Mature amyloid fibrils. xy/z scale bars (nm): 200/10 (A), 100/7 (B), 250/20 (C), 100/25 (D), 200/35 (E), 100/30 (F), 1000/40 (G), 400/40
(H), 200/40 (I), 1000/40 (J), 500/40 (K), 200/20 (L), 300/30 (M), 100/20 (N), 200/20 (O), 200/20 (P), 100/20 (Q), 100/50 (R), and 100/50 (S). Coding: wtAS
(magenta solid circles), wtASþ 2.5%AS-MFC (orange solid circles), 4C (blue solid circles), 37C (green solid circles), 70C (red solid circles); in all cases
150 mM protein, 25 mM Na-PO4 pH 6.2, 0.02% NaN3. All samples (except E) were spin-coated (see Materials and Methods for details).
Biophysical Journal 102(5) 1127–1136
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37 ˚C 
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4 ˚C 
E 
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H 
latent  
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productive  
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fuzzy  
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O 
fuzzy  
fibers 
70 ˚C 
R 
denuded 
fibers 
37 ˚C 
S 
mature amyloid  
fibrils 
37 ˚C 
AFM 
Substructure core core core core core fiber core fiber fiber fuzzy fiber fuzzy fiber fibril 
Height 4.5 ± 1.4 13 ± 8 25 ± 12 28 ± 15 20 ± 12 22 ± 10 27 ± 15 17 ± 11 10 ± 4 3 ± 1 13 ± 4 6 ± 3 14 ± 4 16 ± 5 
Diameter 30 ± 8 240 ± 104 330 ± 74 290 ± 110 305 ± 120 31 ± 14 405 ± 88 33 ± 14 32 ± 14 45 ± 24 48 ± 18 155 ± 24 48 ± 12 49 ± 10 
Period - - - - - 39 ± 10 - 62 ± 13 150 ± 30 - 80 ± 30 - 60 ± 24 220 ± 120 
P2A - 1.2 ± 0.2 1.0 ± 0.2 1.2 ± 0.3 - - - - - - 
N 413 59 22 10 38 7 10 7 62 90 
CRYO-ET 
beaded threads colloidal masses latent acuna 
CRYO-ET 
Diameter 5.0 ± 0.5 48 ± 5 540 
N 121 9 1 
FIGURE 3 Dimensions of supramolecular forms of AS resolved by AFM and cryo-ET. Core refers to a central condensed structure, surrounded by a fuzzy
periphery in the indicated cases. The panel designations correspond to those in Fig. 2. See Materials and Methods for other definitions and image analysis
procedures. The AFM analyses were performed on 55 or 1010 mm images. Note that lateral dimensions (AFM) are biased to larger values due to the
influence of the finite tip diameter. For extensive characterizations of fibrillar forms of AS by AFM see Sweers et al. (50) and van Raaij et al. (51). All dimen-
sions are given in nanometers. N, number of analyzed structures. Data from >10 independent reproducible experiments performed over 1.5 years.
Supramolecular Non-Amyloid Intermediates 1131At 37C (Fig. 2E), acunas have amore distinct rim and one
to five prominent interior particles 10–20 nm in height. We
ascribe a ‘‘cradle’’ property to these structures and denote
them as productive because of the phenomenon evident in
panels F–N. In samples maintained at R37C under agita-
tion, the emergence ofR1fibers, generally oriented symmet-rically along a major axis of the acuna, can be observed. The
fibers arise within the confines of the acuna (Figs. 1, B and
C.3, and 2, F–N; for greater detail see Fig. S13 and
Fig. S14) and grow, apparently by addition at both ends,
emerging from the acuna and attaining a length of up to a few
micrometers. These structures (denoted as fuzzy fibers, ffs)FIGURE 4 Cryo-ET of a latent acuna. (A) A z-axis slice
(No. 51 of 77 slices) from a 3D tomogram of wtAS incu-
bated at 4C for 3 days. The arrows indicate a beaded
thread traversing the acuna. (B) An annotated central
cutaway of the same acuna (yellow). A network of beaded
threads radiates outward from the acuna (yellow, center),
forming connections with surrounding islands of AS
(yellow), presumed to be fbs undergoing accretion by the
acuna. The color bar indicates a z-axis gradation in color
(purple to red) for the annotated beaded threads, and
applies to panels C–E. (C) A 20-nm-thick section from
the annotated tomogram, delineating the fibrillar intercon-
nections between the central and surrounding masses. A
zoomed view of the boxed area is shown in panel E. (D)
A 200-nm thick section of the inner regions of the acuna,
containing interconnected condensed colloidal masses
(purple, indicated by the red arrows). Inset: an AFM
image of an acuna from the same preparation; white scale
bar: 300 nm. (E) A zoomed, edited view (boxed area,
panel C) of two islands of AS (yellow) interconnected by
beaded threads. All black scale bars: 100 nm.
Biophysical Journal 102(5) 1127–1136
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20–40 nm (core) and 20–70 nm, including fuzziness) and
often curved, and their extensions beyond the border of the
acuna exhibit a characteristic fuzzy lateral envelope, which
in some cases is regular and in others is modulated in width.
At 70C, the ffs are contracted (smaller period and greater
height and diameter). More detailed views are given in
Fig. 2, I,L–N. In panels Fig. 2, J,K, andM, the linking or cate-
nation ofR2 acunas by a single long ff, several micrometers
in length, is evident. The strong ESIPT response appears to
arise at this step as well.
The reaction then proceeds to the next stage, in which the
transient acunas disappear. The segmented ffs are released
(Fig. 2, O–Q) and subsequently transform into denuded
fibers (dfs, panel R) that lack fuzziness and show less curva-
ture and a substantially greater height (~15 nm) and diam-
eter (35–60 nm), and reduced periodicity (35–85 nm;
Fig. 3). The final conversion is to mafs (panel S) with
a height of 10–20 nm, a diameter of 40–60 nm, variable
periodicity (100–350 nm), and lengths that in some cases
exceed 5 mm. These constitute the exclusive supramolecular
species at the end of the overall reaction (72 h in Fig. 1 A).
We used a number of controls to validate the AFM proce-
dures, and explored other conditions (see Supporting Mate-
rial for detailed descriptions). Latent acunas required
R 200 mM AS and 3–5 days of incubation at 4C to form,
but were then stable for >1 week. Acunas that formed at
37C (Fig. S2) but maintained thereafter at 4C (Fig. S3)
did not progress spontaneously to ff induction. Acunas that
evaporated on mica for 30 min yielded images similar to
those acquired after spin-coating, excluding the latter proce-
dure as a source of artifactual structures (Fig. S4). A sample
dilution to 7 mM protein and ~1 mM buffer led to partial or
complete disruption of the acunas (Fig. S5). Dilution to
3 mMprotein at a constant 2.5mMbuffer preserved the struc-
tures (Fig. S6), whereas 25 mM buffer led to the grouping of
two to four acunas and the appearance of fuzzinesswith some
surface fibrillation (Fig. S7). Washing spin-coated acunas
with water released and/or disintegrated them, leaving
residual depressions in the underlying monomer layer and
backbones/skeletons of the nascent ffs (Fig. S8). AFM under
liquid revealed low-resolution images of structures with the
general acuna shape and size (Fig. S9). Taken together, these
experiments indicate that the protein concentration and
ionic strength have a significant effect on the formation,
appearance, and stability of the acunas, in accordance with
expectation considering the high-density packing revealed
by cryo-ET (see below). Higher ionic strength promotes
denser packing, probably due to electrostatic screening.
Finally, latent acunas deposited on an atomically flat glass
substratewere clearly discernible byAFM, excluding a direct
influence of the mica on the distribution and nature of the
perceived supramolecular structures (Fig. S10).
The key role of temperature in dictating the course of
reaction was explored further in a two-stage experimentBiophysical Journal 102(5) 1127–1136involving fluorescence and AFM imaging (Fig. S11 and
Fig. S12). Two samples (samples 1 and 2) of 300 mM
wtAS were incubated at 4C. Sample 2 also contained 3%
of labeled protein (AS140C-MFC). Emission spectra were
recorded after incubation at 4C for 5 days. Additional unla-
beled protein was added to both samples, and 3% of labeled
protein was added to sample 1, resulting in the same final
concentration of labeled and unlabeled protein in both
samples. Incubation was resumed at 37C with agitation.
A dramatic increase in fluorescence, especially of the
T* band, as well as the formation of productive acunas
was observed in both samples (Fig. S12, e and f). They
were then maintained at 4C for 15 days, after which the
T* band diminished by 50%. Fibrils and small round struc-
tures were observed by AFM. Finally, the samples were sub-
jected to another 2 days of incubation at 37C, leading to an
increase of the T* band to the highest levels observed in the
experiment, and to the formation of long, tangled mafs. This
experiment confirmed that 1), the labeled protein does not
influence the early (or late) course of aggregation (samples
1 and 2 were indistinguishable); 2), in the reaction sequence,
the protein monomer gives rise to small oligomeric struc-
tures and then to latent acunas; and 3), higher temperature
is required for the formation of productive acunas, fibers,
and, finally, amyloid fibrils.Cryo-ET
Unfixed, unstained samples of latent acunas were imaged by
cryo-ET, vitrified directly from solution (25). We report here
initial cryo-ET data for acunas formed at 4C for 3 days
from wtAS þ 2.5% AS-A140C-MFC (Fig. 4). A single
structure was analyzed extensively and is featured in this
report; others similar in size and contrast were evident
throughout the electron microscopy grid (Fig. S15, b and c,
and Fig. S16).
Fig. 4 A shows a single z-axis slice of a reconstructed 3D
tomogram, revealing an acuna as a high contrast oblong
object of 0.40.6 mm. The internal structure consists of
two characteristic elements: beaded threads and condensed
colloidal masses (48 5 5 nm; Fig. 3). The acuna and its
associated features are annotated in different colors, as
shown in Fig. 4, B–E. An example of a beaded thread is
highlighted by arrows in Fig. 4, A and C.
The diameter of the beads constituting the linear threads
is 5.05 0.5 nm, in correspondence with models of potential
oligomeric structures of AS (Fig. 5). The beaded threads
appear to arise from the condensed colloidal masses and
form a connective network within the acuna (Fig. 4 D)
and at its surface (Fig. 4, C–E).DISCUSSION
We have established the existence of the family of acunas
and related intermediates in the aggregation of AS. Their
FIGURE 5 Sequential aggregation scheme (SAS) for a-synuclein. The
molecular, colloidal, and fibrillar stages are depicted in terms of distinct
reaction steps (numbered) with different degrees of reversibility (arrows)
and of thermodynamic nature (exergonic: spontaneous reactions at low or
high temperature; endothermic: reactions requiring elevated temperature).
Step 1: Oligomerization (conjectural models of AS monomer, dimer, and
hexamer) and end-to-end association of oligomers (beaded threads; cryo-
ET annotated reconstruction). Step 2: Fuzzy ball condensation. Step 3:
collapse to latent acunas. Step 4: Activation of productive acunas. Step 5:
Generation and release of fuzzy fibers (the open arrow indicates a template
function of the productive acunas). Step 6: Loss of fuzziness (denuded
fibers) and transformation to other prefibrillar structures. Step 7: Conforma-
tional transition to the amyloid fibrillar form. Step 8: Fibrillar growth by
mechanical fragmentation and terminal extension via scavenging of mono-
mers and oligomers. Other associated processes are not shown, including
1), covalent modification (oxidation, phosphorylation, sumoylation, and
ubiquitination), physiological interactions (ligands, proteins, membranes/
vesicles, and organelles), PD pathological structures (Lewy bodies and
neurites); 2), dehydration and ionic screening (solvent/solute) leading to
alternative fibrillar mesh and amorphous precipitates; 3), cold-induced frag-
mentation in vitro (52); and 4), chemical inhibition and reversal of distinct
steps. Cytotoxicity may originate primarily from the colloidal species.
Images are not to uniform scale; scale bars: 5 nm (black), 100 nm (gray
and white). See Fig. 2 and text for additional details.
Supramolecular Non-Amyloid Intermediates 1133interrelationships define a concerted sequential reaction
mechanism with distinct thermodynamic and kinetic nodes.
In a recent comprehensive review, Morris et al. (26) identi-
fied >18 methods for studying amyloid aggregation and
proposed five mechanisms for monomer polymerization.
Many of these approaches are phenomenological due to
the absence of explicit knowledge about presumed interme-
diates such as the amyloid protofibril (27). In this study,
a versatile environment-sensitive ESIPT fluorescent probe
(15) enabled the detection (Fig. 1) and systematic explora-
tion by high-resolution AFM and cryo-ET of transient
species that appeared early in the reaction (Figs. 2 and 4).The two techniques in tandem revealed the size and
morphology of the novel supramolecular intermediate, the
latent acuna. The cryo-ET images provided high-resolution
views of the vitrified entities in solution, revealing the
complex internal structure of latent acunas and permitting
a more accurate interpretation of the complementary topo-
graphic (surface) view supplied by AFM. We adopted an
intentionally descriptive terminology for the complex,
previously unreported supramolecular species to avoid
confusion with terms that have generally been applied to
fibrillar forms.
In accordance with Xu (28,29), we propose that AS
and possibly other amyloid proteins self-associate in
a manner reflecting the general properties of colloidal
systems (1 nm to 1 mm in size) modulated by features
conferred by the nature and sequence of the amino acid
(aa) side chains. This consideration and the available
experimental data lead us to propose the multistate sequen-
tial association scheme (SAS) depicted in Fig. 5. We
propose a sequence of distinct structural transformations
(numbered) that occur in three stages defined by the size
range and nature of the species involved: 1), molecular; 2),
colloidal; and 3), fibrillar. We also distinguish between the
initial exergonic steps, i.e., those occurring spontaneously
even at low temperature (4C) and the subsequent endo-
thermic steps, requiring elevated temperature (e.g.,
R37C). The SAS is clearly more complex in terms of
structural diversity than the three-state (monomer, oligomer,
and fibril) mechanism that is generally invoked for amyloid
assembly, although it fulfills the predictions based on
consideration of the physical equilibria treated in such
formulations (30).
The molecular stage of aggregation (Fig. 5, step 1)
involves monomeric and oligomeric states of AS. Although
AS is generally regarded as an intrinsically disordered
protein, according to NMR/MS data (31,32), it adopts
a compact (~5 nm) spherical or ellipsoidal structure in solu-
tion. Regardless of the particular fold of an individual AS
monomer, the asymmetrical distribution of charged amino
acids gives rise to a strong dipole moment. AS exhibits
a pronounced tendency to form stable dimers (32,33) and
higher-order oligomeric species. A recent study suggested
that AS may exist physiologically in a tetrameric, a-helical
aggregation-resistant form (34). Although this finding
remains to be confirmed, it is evident that pauci-oligo-
meric-associated states of AS constitute the building blocks
of the filamentous and condensed features revealed by cryo-
ET and AFM.
The colloidal stage (steps 2–6) comprises the compaction
of the discrete AS oligomeric and filamentous forms into
particles (fbs). We propose that the condensed colloidal
masses seen by cryo-ET and AFM originate from the fbs,
and that the beaded threads constitute the fuzziness identi-
fied by AFM, presumably stabilizing the supramolecular
structure and recruiting material from the periphery.Biophysical Journal 102(5) 1127–1136
1134 Fauerbach et al.According to the linear colloidal aggregation model
proposed by Xu (28,29), aggregation of molecules into
colloidal particles is driven by surface energy minimization
resulting from compensation of long-range charge-charge
and short-range van der Waals interactions. Specific site-
site or structure-structure interactions may not be involved.
Because of the omnidirectionality of the operative forces,
the colloidal particles are spherical and remain in suspen-
sion due to intrinsic þ adsorbed charge and surface poten-
tial. However, inherent attractive interactions must exist,
in view of the accretion zones and ultimate condensation
into the supramolecular acunas. That is, the fuzziness
observed by AFM in numerous intermediates constitutes
a type of molecular Velcro, corresponding to the fine beaded
threads revealed by cryo-ET as a matrix interlinking the
globular masses of more densely packed oligomers (Fig. 4).
Agitation and elevated temperature (e.g., 37C) are
required for progression to the next and perhaps most crit-
ical step (5) (Fig. 5), the generation of productive acunas
and extrusion of linear aggregates, the ffs. After efficient
nucleation on the productive acunas, linear growth is
presumed to progress by catenation of fbs, perhaps with
the participation of other free oligomeric forms. The acunas
may facilitate conformational rearrangements in a manner
reminiscent of chaperones. For example, a nonclassical
(physiological?) chaperone activity of AS in the mainte-
nance of presynaptic SNARE-complexes has been reported
(35). The strong ESIPT signal is indicative of a reduced
polarity in the immediate microenvironment of the probe,
from which we infer that the surrounding structure is
more condensed and less exposed to the aqueous medium.
The directionality of growth is rationalized by a key feature
of the linear colloidal aggregation model: the appearance of
an asymmetric charge distribution leading to a finite dipole
moment in the colloidal spheroids. A possible mechanism
for generating the required dipole-dipole asymmetry (29)
is the formation of a-sheet secondary structure, proposed
by numerous investigators (29,36–39) as a transient phase
in protein amyloidosis. In the a-sheet configuration, all of
the NH groups are on one side and all of the carbonyl groups
are on the other side of the polypeptide strand. Shape
complementarity (40) may also confer specificity to this
process.
Free ffs arise from and at the cost of the productive acu-
nas, which disappear. The modulations and multiple attach-
ments depicted in Figs. 1 B and 2, J and M, suggest that ff
catenates may themselves serve as accretion centers as
they grow, generating secondary acunas. The ffs then evolve
into mafs via intermediate denuded fibers (dfs), which are
distinguishable by their lack of fuzziness (Fig. 2 R). We
propose that fuzziness is an inherently dynamic, tenuous
property that reflects the general colloidal state of the
system as well as the protein identity, i.e., the primary
sequence. Although fuzziness survives moderate degrees
of isotonic dilution, it is lost upon centrifugation or size-Biophysical Journal 102(5) 1127–1136exclusion chromatography of fbs and ffs. These procedures,
which are often used in the fractionation of amyloid
oligomers, lower the free protein concentration. Consid-
ering that the subsequent step of fibrillization does the
same (see below), we conclude that fuzziness reflects the
noncovalent association of AS monomer and/or oligomers
with a catenated fiber core. Thus, it appears that ffs have
little relation to the fuzzy coat of tau fibrils, which is not
visualized by AFM and is an integral part of the core
protein, being released only by proteolysis (41). A recent
study of prefibrillar intermediates of wtAS aggregation,
seeded by an aggregation-incompetent triple mutant
A30P/A56P/A76P (TP aS), featured electron microscopy
images very reminiscent of ffs (see Fig. 2 A of Karpinar
et al. (42)).
The fibrillar stage (SAS, steps 7 and 8) is unique in many
respects, the most conspicuous of which is the concerted
transition in the secondary structure of the ffs (via dfs) to
the cross-b-sheet conformation constituting the cross-
sectional element of the amyloid fibril (maf). Xu (29)
provided a detailed description of a proposed a-sheet to
cross-b-sheet transition based on theoretical and experi-
mental considerations. Such a transformation could nucleate
internally or terminally in the fiber under the influence of
small variations in the concentrations of effector molecules.
This is an attractive hypothesis with regard to disease evolu-
tion as well as the design of therapeutic strategies. Tem-
plated conformational change may also play a role (43).
Once the mafs emerge, they supplant the preceding acuna-
dependent growth mechanism by propagation via mature
amyloid reactive sites. The rapid addition of monomer
and/or oligomeric AS units (e.g., stable dimers (32,33)) is
very efficient (26) in scavenging the monomer and thereby
displacing the dynamic equilibria of the acuna manifold
(preamyloid steps 1–6) back to the monomeric and oligo-
meric states. In this respect, the stage of fibrillar growth
short-circuits the system and renders it largely irreversible,
such that the final reaction products in vitro and possibly
in vivo (44) are mafs and residual, depleted monomer-olig-
omer. Of course, such a scenario applies only to a reaction
triggered as a unique synchronous event. In the more likely
continuous steady-state process applicable in the cell,
including in the context of PD, all species of the SAS would
be represented in the AS population distribution.
Of the numerous noncanonical features of the proposed
mechanism for the aggregation of AS, distinct from that
of Ab (45), the most significant is that neurotoxicity may
primarily involve soluble, molecular species that lack
the amyloid features characteristic of the classical mafs
(46), notably a cross-b-sheet secondary structure and the
tendency to form an entangled network. Acunas and
ffs exhibit great potential for toxic gain-of-function given
their inherently complex surface structure, and the
influence of multiple influences in the cellular context.
These include AS concentration and modification(s), and
Supramolecular Non-Amyloid Intermediates 1135interactions with other proteins, membranes, compartments,
and organelles.
The acuna entities may also serve as key elements of
other amyloid protein systems. A recent study of Ab peptide
self-assembly (47) featured fluorescence images that may
correspond to AS acunas, and AFM images of amyloido-
genic yeast Sup35 aggregation intermediates are reminis-
cent of the highly segmented ffs (48). We surmise that
acunas have previously eluded detection due to 1), their
transient nature; 2), their low fractional concentration (esti-
mated by preliminary ultracentrifugation analysis as <20%
at the acuna stage); 3), the requirement for a high protein
concentration; and 4), the use of destabilizing AFMwashing
protocols. A major challenge raised by this study is the need
to devise a means of fractionating the molecular species rep-
resented in Fig. 5 so as to determine their interactomes,
toxicities, and antigenicities (6). In the event that the latter
are strong and specific, prophylactic and/or therapeutic
vaccination strategies for preventing or reversing the disease
state are conceivable. In parallel, one could screen for selec-
tive agents (49) capable of reducing the load of specific
neurotoxic species, either directly or by inhibiting the entry
or facilitating the exit from their respective reaction
compartments (Fig. 5).SUPPORTING MATERIAL
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